Patent details

301016 Product Name: Combinatie van daunorubicine en cytarabine

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301016
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2768484
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
301016
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1308
Marketing Authorization Type:
EEA
Marketing Authorization Date:
27/08/2018
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
25/10/2019
First Marketing Authorization date:
27/08/2018
Grant date:
16/04/2020
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
29/10/2019
SPC/SPC Extension Expiration Date:
26/08/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
25/10/2019
 
 

 

Name:
Jazz Pharmaceuticals Research LLC
Address:
3170 Porter Drive, Palo Alto, CA 94304, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
25/10/2019
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
22/24
Publication date:
29/05/2024
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
17/20
Publication date:
22/04/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
44/19
Publication date:
30/10/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/10/2032
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
16/04/2020 Outgoing Correspondence Decision grant 1 PDF /3/6/7/5/7/0800475763/docs/301016_0_338954l504a.pdf
16/04/2020 SPC Documents Certificate SPC 1 PDF /3/6/7/5/7/0800475763/docs/301016_1_supplprotectioncertificate20200416104245686.pdf
15/04/2020 Incoming Correspondence Paper Incoming Correspondence Paper 3 PDF /3/6/7/5/7/0800475763/docs/301016_2_incomingcorrespondencepaper20200415122451321.pdf
15/04/2020 SPC Documents Annex SPC 103 PDF /3/6/7/5/7/0800475763/docs/301016_5_supplprotectioncertificate20200415122739333.pdf
05/03/2020 Outgoing Correspondence Letter to applicant 1 PDF /3/6/7/5/7/0800475763/docs/301016_7_327802l173.pdf
30/10/2019 Outgoing Correspondence Confirmation receipt request 1 PDF /3/6/7/5/7/0800475763/docs/301016_3_306594l174.pdf
25/10/2019 SPC Documents Summary of the characteristics of the product 18 PDF /3/6/7/5/7/0800475763/docs/301016_4_supplprotectioncertificate20191029012649277.pdf
25/10/2019 SPC Documents Annex SPC 2 PDF /3/6/7/5/7/0800475763/docs/301016_6_supplprotectioncertificate20191029012649351.pdf
25/10/2019 SPC Documents Annex SPC 13 PDF /3/6/7/5/7/0800475763/docs/301016_8_supplprotectioncertificate20191029012649428.pdf
25/10/2019 SPC Documents Marketing Authorization SPC 3 PDF /3/6/7/5/7/0800475763/docs/301016_9_supplprotectioncertificate20191029012649186.pdf
25/10/2019 Application Form First filed application form 3 PDF /3/6/7/5/7/0800475763/docs/301016_10_applicationform20191029012648935.pdf
25/10/2019 SPC Documents Accompanying letter SPC 1 PDF /3/6/7/5/7/0800475763/docs/301016_11_supplprotectioncertificate20200827102259930.pdf